Episode
Non-Small Cell Lung Cancer and Therapeutic Targets Beyond EGFR — Year in Review Series on Relevant New Datasets and Advances
- Podcast
- Lung Cancer Update
- Published
- Jun 10, 2025
- Duration seconds
- 3502
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/lung-cancer-update-827388/episodes/non-small-cell-lung-cancer-and-therapeutic-targets-beyond-egfr-year-in-review-series-on-relevant-new-datasets-and-advances/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/lung-cancer-update-827388/non-small-cell-lung-cancer-and-therapeutic-targets-beyond-egfr-year-in-review-series-on-relevant-new-datasets-and-advances.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Dr Jessica J Lin from Massachusetts General Hospital in Boston and Dr Joel W Neal from Stanford Cancer Institute in California summarize major treatment advances over the past year and review relevant ongoing clinical trials using targeted therapies for patients with non-small cell lung cancer. CME information and select publications here .